Press release
Candidiasis Therapeutics Market Size, Key Players, Demand And Outlook By 2033
Candidiasis Therapeutics Market Size
As per the report, the candidiasis therapeutics market size has grown steadily in recent years. It will grow from $3.06 billion in 2023 to $3.19 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The candidiasis therapeutics market size is expected to see steady growth in the next few years. It will grow to $3.66 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13182&type=smp
Rising Fungal Infection Rates Fueling Growth In The Candidiasis Therapeutics Market
The growing incidence of fungal infections is expected to propel the growth of the candidiasis therapeutics market going forward. Fungal infections are illnesses caused by various fungi that can affect the skin, mucous membranes, and internal organs in humans. The rising number of individuals with compromised immune systems and individuals with fungal infections increases the susceptibility to candidiasis, creating opportunities for manufacturers to develop and supply specialized and more effective antifungal drugs that target the underlying fungal pathogens, relieve symptoms, prevent complications, promote patient recovery, reduce the spread of Candida infections within healthcare facilities, and contribute to better patient outcomes. For instance, in July 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, fungal infection-related hospitalizations reached a total of 59,212 by 2021, with the rate of these hospitalizations increasing from 25.0 in 2020 to 26.8 in 2021 per 10,000 hospitalizations, with an average annual increase of 8.5%. Moreover, the fungal hospitalizations with the highest death rates among COVID-19 patients were linked to aspergillosis (57.6%), invasive candidiasis (55.4%), mucormycosis (44.7%), and unspecified mycoses (59.0%). Therefore, the growing incidence of fungal infections will drive the growth of the candidiasis therapeutics market.
Innovative Drugs Transforming The Candidiasis Treatment
Major companies operating in the candidiasis therapeutics market are developing innovative drugs such as BREXAFEMME (ibrexafungerp tablets) to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in adult women. BREXAFEMME (ibrexafungerp tablets) is an oral, non-azole medication for the treatment of vulvovaginal candidiasis (VVC) and the reduction of the incidence of recurrent vulvovaginal candidiasis (RVVC), also known as chronic yeast infections. For instance, in December 2022, Scynexis Inc., a US-based pharmaceutical company, received the US Food and Drug Administration (FDA) approval for BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC) and the reduction in the incidence of recurrent vulvovaginal candidiasis (RVVC), also known as chronic yeast infections. BREXAFEMME works by blocking the growth of Candida albicans, the fungus that causes VVC. Moreover, it is a safe and effective treatment option for vulvovaginal candidiasis (VVC). It is also available only by prescription, with a recommended dose of one 150-mg capsule taken orally once daily for one day.
The candidiasis therapeutics market covered in this report is segmented -
1) By Treatment Type: Medication, Surgery, Other Treatments
2) By Anatomy Type: Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis
3) By Mode of Administration: Injectable, Oral, Other Mode of Administrations
4) By Patient Population: Adults, Pediatrics
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13182&type=discount
Major companies operating in the candidiasis therapeutics market report are Pfizer Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc., GSK plc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Bruker Corporation, Lupin Limited, Galapagos NV, Basilea Pharmaceutica Ltd., WOCKHARDT Limited, Pacgen Life Science Corporation, Cidara Therapeutics Inc., Ablynx NV, Amplyx Pharmaceuticals Inc., NovaDigm Therapeutics Inc., SCYNEXIS Inc., Medivir AB, Mycovia Pharmaceuticals Inc., NovaBiotics Inc., Matinas BioPharma Holdings Inc.
Contents of the report:
1. Executive Summary
2. Candidiasis Therapeutics Market Report Structure
3. Candidiasis Therapeutics Market Trends And Strategies
4. Candidiasis Therapeutics Market - Macro Economic Scenario
5. Candidiasis Therapeutics Market Size And Growth
…..
27. Candidiasis Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Candidiasis Therapeutics Market Size, Key Players, Demand And Outlook By 2033 here
News-ID: 3573943 • Views: …
More Releases from The Business research company
Leading Companies Fueling Growth and Innovation in the Automotive Solenoid Marke …
The automotive solenoid market is on the verge of significant expansion as advancements in technology and vehicle electrification continue to accelerate. Increasing integration of smart systems and the growing demand for efficient, eco-friendly automotive solutions are set to drive this market's development through the end of the decade.
Expected Growth Trajectory for the Automotive Solenoid Market by 2030
The automotive solenoid market is projected to reach a valuation of $7.81 billion…
Automotive Night Vision System Market Analysis: Major Segments, Strategic Develo …
The automotive night vision system market is set to experience significant expansion over the coming years, driven by technological advancements and growing safety demands. As vehicle manufacturers continue to integrate more sophisticated safety features, this market shows promising potential for rapid growth and innovation through 2030.
Projected Expansion of the Automotive Night Vision System Market Size Through 2030
The market size for automotive night vision systems is anticipated to reach $7.24…
Segment Analysis and Major Growth Areas in the Automotive HVAC Market
The automotive HVAC market is on a trajectory of significant growth as vehicle climate control systems evolve with advanced technologies. Innovations aimed at improving energy efficiency and passenger comfort are driving the sector forward, setting the stage for substantial expansion through 2030. Let's explore the current market size, key players, influential trends, and detailed segment insights shaping this dynamic industry.
Automotive HVAC Market Size and Growth Outlook Through 2030
The automotive…
Key Strategic Developments and Emerging Changes Shaping the Automotive Electroni …
The automotive electronic controller market is on track for impressive expansion as technology continues to transform the automotive sector. With the industry embracing smarter and more connected vehicle systems, the demand for advanced controllers that manage and optimize vehicle functions is rapidly increasing. Below, we explore the market's projected growth, key players, notable trends, and the main segments shaping this dynamic field.
Projected Market Size and Growth of the Automotive Electronic…
More Releases for Candidiasis
Candidiasis Market New Product Development & Latest Trends
Introduction
Candidiasis, a fungal infection caused by Candida species, represents a major healthcare challenge worldwide. While Candida albicans is the most common pathogen, emerging strains such as Candida auris are raising global concerns due to their high resistance to antifungal drugs. Candidiasis can affect the mouth (oral thrush), genital areas, bloodstream, and internal organs, with systemic infections often proving life-threatening, especially in immunocompromised patients.
The growing prevalence of hospital-acquired infections (HAIs), rising…
Rising Fungal Infection Rates Fueling Growth In The Candidiasis Therapeutics Mar …
The Candidiasis Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Candidiasis Therapeutics Market Size and Projected Growth Rate?
Recent years have seen consistent growth in the size of the market for candidiasis therapeutics. This is predicted to further expand from $3.19 billion…
Acute Vulvovaginal Candidiasis Market Beyond Douching: New Treatment Options Dri …
Acute Vulvovaginal Candidiasis Market worth $ 485.54 Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acute Vulvovaginal Candidiasis Market- by Drug Type (Clotrimazole, Nystatin, Fluconazole, , Terbinafine, Terconazole and Other Drug Types), Route of Administration (Oral, Intravenous and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Trends, Industry Competition Analysis, Revenue and Forecast…
Recurrent Vulvovaginal Candidiasis Market - Defeating Recurrent Vulvovaginal Can …
Newark, New Castle, USA: The "Recurrent Vulvovaginal Candidiasis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Recurrent Vulvovaginal Candidiasis Market: https://www.growthplusreports.com/report/recurrent-vulvovaginal-candidiasis-market/8832
This latest report researches the industry structure,…
Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with…
Candidiasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Candidiasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin…
